Pneumonia can occur if Pseudomonas infects the lungs. Hospitalized adults with Pseudomonas and those who have recently ...

Chicago-based Meitheal Pharmaceuticals, along with its Chinese parent, was busy in 2024, adding both biosimilar drugs and ...

usually necessitates a more prolonged course of intravenous antibiotics as compared to pneumonia caused by the less virulent and more antibiotic sensitive Mycoplasma pneumoniae. Antibiotic ...

A study in The Annals of Family Medicine explored how chest X-ray results influence antibiotic initiation by general practitioners in France when managing patients with suspected pneumonia.

Severe pneumonia caused by human metapneumovirus in an immunocompetent adult highlights diagnostic challenges and underscores ...

HMPV causes mild illness in most adults. However, it poses a higher risk to specific vulnerable groups. These people need to ...

Wockhardt's novel antibiotic Miqnaf approved for CABP treatment, offering a promising monotherapy option for MDR pathogens.

Miqnaf is an antibiotic for treatment of community-acquired bacterial pneumonia, including those caused by multi-drug ...

Walking pneumonia differs from other respiratory infections like flu or cold because it quickly settles in the chest and can leave people feeling short of breath. With walking pneumonia, any ...

Central Drugs Standard Control Organization (CDSCO) approved antibiotic Nafithromycin, sold under Miqnaf brand, as a new treatment for community-acquired bacterial Pneumonia (CABP) in adults.